Additive value of diabetes and peripheral arterial disease in the risk stratification of patients admitted after an acute coronary syndrome: a subanalysis of the PAMISCA Study
Francisco J. Pastor‐Pérez(Hospital Universitario Virgen de la Arrixaca), Vicente Bertoméu, Juan Quiles(Hospital Universitari Sant Joan D'Alacant), Isidoro González-Maqueda(Hospital Universitario La Paz), Luis Rodrı́guez Padial(Complejo Hospitalario Universitario de Toledo), Pedro Morillas-Blasco(Hospital Universitari Sant Joan D'Alacant), Josep Guindo-Soldevila(Deleted Institution), Pilar Mazón‐Ramos(Universidade de Santiago de Compostela), Federico Soria Arcos(Hospital Universitario Virgen de la Arrixaca), José Ramón González‐Juanatey(Centro de Investigación en Red en Enfermedades Cardiovasculares)
Cited by 2
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Periodontitis and cardiovascular diseases: Consensus report
|Journal Of Clinical Periodontology|2020|1.5k
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
|European Heart Journal|2020|282
Periodontitis and Cardiovascular Diseases. Consensus Report
|Global Heart|2020|274
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
|European Journal of Heart Failure|2023|187